{
  "ticker": "JAZZ",
  "company_name": "Jazz Pharmaceuticals plc",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05485831",
      "title": "Epidyolex\u00ae in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex",
      "start_date": "2025-02-24",
      "completion_date": "2026-01",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT02073474",
      "title": "An Observational Post-Marketing Safety Registry of Sativex\u00ae",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Multiple Sclerosis, Diabetes, Cancer, Neuropathic Pain",
      "start_date": "2011-02",
      "completion_date": "2015-01",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT02224703",
      "title": "GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Epilepsy, Dravet Syndrome",
      "start_date": "2015-04-13",
      "completion_date": "2018-04-09",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT05244239",
      "title": "Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8",
      "start_date": "2022-07-27",
      "completion_date": "2027-07-28",
      "enrollment": 0,
      "sponsor": "Emory University"
    },
    {
      "nct_id": "NCT03849456",
      "title": "Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Autism Spectrum Disorder",
      "start_date": "2020-01-07",
      "completion_date": "2020-05-26",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT02087306",
      "title": "Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Adenovirus Infection",
      "start_date": "2014-03",
      "completion_date": "2016-08",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT01161641",
      "title": "Pilot/Ph I Safety and Efficacy of ODSH in Protein Losing Enteropathy Secondary to Single Ventricle Palliative Surgery",
      "status": "TERMINATED",
      "phase": "PHASE1",
      "condition": "Protein Losing Enteropathy",
      "start_date": "2010-07",
      "completion_date": "2012-02",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT05869773",
      "title": "A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Narcolepsy",
      "start_date": "2023-06-26",
      "completion_date": "2025-03-10",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT04075747",
      "title": "A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Acute Myeloid Leukemia",
      "start_date": "2019-12-02",
      "completion_date": "2023-09-12",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    },
    {
      "nct_id": "NCT04745026",
      "title": "Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Autism Spectrum Disorder",
      "start_date": "2021-05-31",
      "completion_date": "2023-12-21",
      "enrollment": 0,
      "sponsor": "Jazz Pharmaceuticals"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "": 4,
      "PHASE3": 17,
      "PHASE1": 14,
      "PHASE2": 13,
      "PHASE4": 1,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "RECRUITING": 6,
      "COMPLETED": 34,
      "TERMINATED": 5,
      "UNKNOWN": 1,
      "APPROVED_FOR_MARKETING": 1,
      "ACTIVE_NOT_RECRUITING": 2,
      "NOT_YET_RECRUITING": 1
    },
    "active_trials": 8,
    "completed_trials": 34,
    "conditions": [
      "Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma",
      "Acute Myelogenous Leukemia",
      "Acute Myeloid Leukemia",
      "Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Diffuse Large Cell Lymphoma, Gray Zone Lymphoma, Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, Hodgkin Lymphoma",
      "Acute Myeloid Leukemia, Myeloid Neoplasm",
      "Adenovirus Infection",
      "Advanced Cancer, Metastatic Cancer, Solid Tumor",
      "Advanced Pheochromocytoma and Paraganglioma, PCPG",
      "Autism Spectrum Disorder",
      "Binge Eating Disorder",
      "CMV",
      "COVID, Sars-CoV2, COVID-19, Acute Respiratory Distress Syndrome",
      "Coronary Artery Stenosis",
      "Detrusor Overactivity, Multiple Sclerosis",
      "Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma, Recurrent Malignant Central Nervous System Neoplasm, Spinal Cord Glioma, World Health Organization (WHO) Grade III Glioma, CNS Tumor, Central Nervous System Tumor",
      "Dyslipidemias, Diabetes Mellitus, Type 2",
      "Effects of Sativex on ECG",
      "Epilepsy",
      "Epilepsy, Dravet Syndrome",
      "Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8",
      "Fibromyalgia",
      "Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma",
      "Healthy",
      "Healthy Participants",
      "Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex",
      "Lung Cancer Patients, Caregivers",
      "Multiple Sclerosis",
      "Multiple Sclerosis, Diabetes, Cancer, Neuropathic Pain",
      "Multiple Sclerosis, Spasticity",
      "Narcolepsy",
      "Narcolepsy, Obstructive Sleep Apnea",
      "Obstructive Sleep Apnea",
      "Opiate Addiction",
      "Parkinson Disease",
      "Protein Losing Enteropathy",
      "Rett Syndrome, RTT",
      "Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer",
      "Spasticity, Multiple Sclerosis",
      "Tuberous Sclerosis Complex, Seizures",
      "Veno-occlusive Disease"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:19:19.028547",
    "search_query": "Jazz Pharmaceuticals plc",
    "url": "https://clinicaltrials.gov/search?term=Jazz+Pharmaceuticals+plc"
  }
}